A unifying model to predict variable drug response for personalised medicine
M. van der Lee, W. G. Allard, R. H. A. M. Vossen, R. F. Baak-Pablo, R. Menafra, B. A. L. M. Deiman, M. J. Deenen, P. Neven, I. Johansson, S. Gastaldello, M. Ingelman-Sundberg, H.-J. Guchelaar, J. J. Swen, S. Y. Anvar
The paper introduces a continuous scale model using full gene sequencing and neural networks to predict CYP2D6 enzyme activity, explaining 79% of interindividual variability in drug response.
bioRxiv · Mar 2, 2020Pharmacology & Toxicology